Last reviewed · How we verify
NCT06258889: EXOPAT
Optimizing Exposure Therapy Via Reward-focused Interventions in Individuals With Public Speaking Anxiety
NA trial testing reward-focused intervention in Public Speaking Fear in 40 participants. Completed in 13 December 2024.
13 December 2024
Quick facts
| Lead sponsor | Philipps University Marburg |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 8 January 2024 |
| Primary completion | 13 December 2024 |
| Estimated completion | 13 December 2024 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- reward-focused intervention
- cognitive flexibility intervention
- exposure
- Psychoeducation
Conditions studied
- Public Speaking Fear — all drugs for Public Speaking Fear →
Sponsor
Philipps University Marburg
Who can join
18 and older, any sex, with Public Speaking Fear. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study aims to examine whether the efficacy of an exposure treatment in individuals with public speaking anxiety can be enhanced by implementing interventions that target reward processes. Optimized exposure enriched with reward-focused interventions will be compared to exposure in combination with interventions targeting cognitive flexibility. The efficacy of the exposure training will be assessed by behavioural and self-report measures of public-speaking anxiety at baseline (before intervention), intermediate-assessment (7-9 days after baseline assessment) and post-assessment (at least 7-9 days after intermediate-assessment). The investigators expect that exposure optimized by implementing reward-focused interventions is more effective in reducing public speaking anxiety compared to exposure in combination with interventions targeting cognitive flexibility.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06258889
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Public Speaking Fear
Currently open trials in the same condition.
- NCT06673407 — Group Exposure Workshops for Socially Anxious Undergraduates · NA · recruiting
Other Philipps University Marburg trials
Trials by the same sponsor.
- NCT07498803 — Sota-ES - Sotatercept in Patients With Congenital Heart Disease and Eisenmenger´s Syndrome · Phase 2 · not yet recruiting
- NCT07388004 — Group Therapy for Major Depression: Comparing Expectation-Focused and Reward-Focused Psychotherapy Approaches · NA · recruiting
- NCT07166692 — Evaluation of a Retrieval Augmented Large Language Model as a Diagnostic Copilot in Rheumatology · NA · completed
- NCT06865534 — Large Language Models to Aid Gynecological Oncology Treatment · NA · recruiting
- NCT06968897 — Neurological Development In Toddlers After Maternal SARS-CoV-2 Infection During Pregnancy · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06258889 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Philipps University Marburg
- Last refreshed: 9 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06258889.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing